D R Webb|M R Butler|J M Fitzpatrick - JoVE Visualize

Showing results (341-350 of 358) with videos related to

Pageof 36

Sort By:

International Immunology|August 1, 1995

Characterization of the epitope recognized by a mAb that reacts differentially with murine suppressor T cellsJ A Kapp, C W Pierce, D R Webb, et al.

The Prostate|May 15, 2001

Caspase 3 expression in benign prostatic hyperplasia and prostate carcinomaA J O'Neill, S A Boran, C O'Keane, et al.

Lancet (London, England)|June 20, 2000

Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre studyJ P Neoptolemos, E A Kemppainen, J M Mayer, et al.

British Journal of Urology|October 1, 1988

1500 cases of renal and ureteric calculi treated in an integrated stone centreG Das, J Dick, M J Bailey, et al.

Endocrine Connections|November 27, 2018

Moderate increases in daily step count are associated with reduced IL6 and CRP in women with PCOSM A Webb, H Mani, S J Robertson, et al.

Diabetes/Metabolism Research and Reviews|December 29, 2016

Cardiovascular risk factors and incident albuminuria in screen-detected type 2 diabetesD R Webb, F Zaccardi, M J Davies, et al.

Postgraduate Medical Journal|March 1, 1995

Prostate disease: management options for the primary healthcare team. Report of a working party of the British Prostate GroupG D Chisholm, S J Carne, J M Fitzpatrick, et al.

Diabetologia|June 4, 2011

Screening for diabetes using an oral glucose tolerance test within a western multi-ethnic population identifies modifiable cardiovascular risk: the ADDITION-Leicester studyD R Webb, L J Gray, K Khunti, et al.

Trials|February 23, 2010

Rationale and design of the ADDITION-Leicester study, a systematic screening programme and randomised controlled trial of multi-factorial cardiovascular risk intervention in people with type 2 diabetes mellitus detected by screeningD R Webb, K Khunti, B Srinivasan, et al.

The Journal of Allergy and Clinical Immunology|February 9, 1999

Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthmaH S Nelson, W W Busse, B P deBoisblanc, et al.

Pageof 36

Showing results (341-350 of 358) with videos related to

Sort By:

Pageof 36

International Immunology|August 1, 1995

Characterization of the epitope recognized by a mAb that reacts differentially with murine suppressor T cellsJ A Kapp, C W Pierce, D R Webb, et al.

The Prostate|May 15, 2001

Caspase 3 expression in benign prostatic hyperplasia and prostate carcinomaA J O'Neill, S A Boran, C O'Keane, et al.

Lancet (London, England)|June 20, 2000

Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre studyJ P Neoptolemos, E A Kemppainen, J M Mayer, et al.

British Journal of Urology|October 1, 1988

1500 cases of renal and ureteric calculi treated in an integrated stone centreG Das, J Dick, M J Bailey, et al.

Endocrine Connections|November 27, 2018

Moderate increases in daily step count are associated with reduced IL6 and CRP in women with PCOSM A Webb, H Mani, S J Robertson, et al.

Diabetes/Metabolism Research and Reviews|December 29, 2016

Cardiovascular risk factors and incident albuminuria in screen-detected type 2 diabetesD R Webb, F Zaccardi, M J Davies, et al.

Postgraduate Medical Journal|March 1, 1995

Prostate disease: management options for the primary healthcare team. Report of a working party of the British Prostate GroupG D Chisholm, S J Carne, J M Fitzpatrick, et al.

Diabetologia|June 4, 2011

Screening for diabetes using an oral glucose tolerance test within a western multi-ethnic population identifies modifiable cardiovascular risk: the ADDITION-Leicester studyD R Webb, L J Gray, K Khunti, et al.

Trials|February 23, 2010

Rationale and design of the ADDITION-Leicester study, a systematic screening programme and randomised controlled trial of multi-factorial cardiovascular risk intervention in people with type 2 diabetes mellitus detected by screeningD R Webb, K Khunti, B Srinivasan, et al.

The Journal of Allergy and Clinical Immunology|February 9, 1999

Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthmaH S Nelson, W W Busse, B P deBoisblanc, et al.

Pageof 36